The role of hypercoagulability in ischemic colitis
Authors:
- Andreas N. KapsoritakisAKAndreas N. Kapsoritakis
- Ioanna A. LinardouILIoanna A. Linardou
- Athanassios K. PsychosAPAthanassios K. Psychos
- Athanassios A. PapageorgiouAPAthanassios A. Papageorgiou
- Nikos C. VamvakopoulosNVNikos C. Vamvakopoulos
- Despina S. KyriakouDKDespina S. Kyriakou
- Spyros P. PotamianosSPSpyros P. Potamianos
- 5 February 2015
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 50 (7) , 848-855
Abstract
The aim of this study is to evaluate the role of thrombophilia-hypercoagulability in ischemic colitis (IC). Thrombophilia and fibrinogen were evaluated in 56 cases of IC and 44 controls with known predisposing factors but no evidence of IC. Thrombophilic factors tested were: protein C (PC), protein S, antithrombin (AT), resistance to activated protein C (APCR), lupus anticoagulant (LA), factor V G1691A mutation (FV Leiden), prothrombin G20210A mutation, methylenetetrahydrofolate reductase (MTHFR) gene C677T and A1298C mutations and plasminogen activator inhibitor-1 (PAI-1) gene 5G/4G and 4G/4G polymorphisms. In IC group were recorded: i) low levels of PC and AT (p = 0.064 and p = 0.022, respectively); ii) low levels of APCR (normal: >2, p = 0.008); iii) high levels of fibrinogen (p = 0.0005); iv) higher number of homozygotes for MTHFR A1298C and C677T mutations (p = 0.061 and p = 0.525 (Pearson chi-square), respectively); v) greater prevalence of 5G/4G and 4G/4G polymorphisms (p = 0.031 (Pearson chi-square)) and vi) higher incidence of LA-positive individuals (p = 0.037, Fischer's exact test). Multivariate analysis was performed to determine the effects of prothrombotic factors in IC. 5G/4G polymorphism of PAI-1 gene (odds ratio (OR) 12.29; 95% confidence interval (CI) 2.26-67.00), APCR (OR 0.089; 95% CI 0.011-0.699) and fibrinogen (OR 1.013; 95% CI 1.003-1.023) were determined as predictors of IC. This study suggests that hypercoagulability, hereditary or acquired, plays an essential role in the manifestation of IC.Keywords
This publication has 29 references indexed in Scilit:
- Systematic review on the treatment of ischaemic colitisColorectal Disease, 2010
- Risk factors associated with the development of ischemic colitisWorld Journal of Gastroenterology, 2010
- Genetic Risk Factors in Young Patients With Ischemic ColitisClinical Gastroenterology and Hepatology, 2008
- Associations of Plasma Fibrinogen Levels with Established Cardiovascular Disease Risk Factors, Inflammatory Markers, and Other Characteristics: Individual Participant Meta-Analysis of 154,211 Adults in 31 Prospective Studies: The Fibrinogen Studies CollaborationAmerican Journal of Epidemiology, 2007
- Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of ischemic stroke: a meta-analysisBlood Coagulation & Fibrinolysis, 2007
- Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosisThrombosis and Haemostasis, 2007
- Thrombophilia Testing in Patients with Venous ThrombosisEuropean Journal of Vascular and Endovascular Surgery, 2005
- Ischemic Colitis Revisited: A Prospective Study Identifying Hypercoagulability as a Risk FactorSouthern Medical Journal, 2004
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994